Literature DB >> 11124654

Adult croup: a rare but more severe condition.

P C Woo1, K Young, K W Tsang, C G Ooi, M Peiris, K Yuen.   

Abstract

We report the first adult patient with virologically confirmed croup caused by parainfluenza virus type 3 and review 10 cases of adult croup described in the English-language literature. Circumstantial evidence of viral infection was present in only 1 other case, in which there was a rise in antibody titer against influenza B virus. Ten patients (91%) required intensive care support. None of the 11 patients died. A comparison was also made between the 11 adults with croup and 43 children hospitalized with severe croup described in a representative paper published in 1984. Adult croup represents an apparently more severe disease entity than pediatric croup. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11124654     DOI: 10.1159/000056301

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  10 in total

1.  A case of adult croup.

Authors:  Stephen R Beckwith
Journal:  Intern Emerg Med       Date:  2008-03-04       Impact factor: 3.397

2.  Uncommon presentation of a common disease: influenza A presenting as adult croup .

Authors:  Nasreen Shaikh; Prudence Dy; Amrit Basnet; Shilpan Shah
Journal:  BMJ Case Rep       Date:  2018-06-04

3.  Human parainfluenza virus 4 outbreak and the role of diagnostic tests.

Authors:  Susanna K P Lau; Wing-Kin To; Philomena W T Tse; Alex K H Chan; Patrick C Y Woo; Hoi-Wah Tsoi; Annie F Y Leung; Kenneth S M Li; Paul K S Chan; Wilina W L Lim; Raymond W H Yung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Execution and Design of an Anti HPIV-1 Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses: An Immunoinformatic Approach.

Authors:  Muhammad Naveed; Allah Rakha Yaseen; Hira Khalid; Urooj Ali; Ali A Rabaan; Mohamed Garout; Muhammad A Halwani; Abbas Al Mutair; Saad Alhumaid; Zainab Al Alawi; Yousef N Alhashem; Naveed Ahmed; Chan Yean Yean
Journal:  Vaccines (Basel)       Date:  2022-05-29

5.  Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis.

Authors:  A Głobińska; M Pawełczyk; A Piechota-Polańczyk; A Olszewska-Ziąber; S Moskwa; A Mikołajczyk; A Jabłońska; P K Zakrzewski; M Brauncajs; M Jarzębska; S Taka; N G Papadopoulos; M L Kowalski
Journal:  Clin Exp Immunol       Date:  2016-11-14       Impact factor: 4.330

6.  Clinical and molecular epidemiology of human parainfluenza virus 4 infections in hong kong: subtype 4B as common as subtype 4A.

Authors:  Susanna K P Lau; Kenneth S M Li; Kam-yu Chau; Lok-yee So; Rodney A Lee; Yu-lung Lau; Kwok-hung Chan; Wilina W L Lim; Patrick C Y Woo; Kwok-yung Yuen
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

Review 7.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

8.  A Narrowing Diagnosis: A Rare Cause of Adult Croup and Literature Review.

Authors:  Jayshil J Patel; Emily Kitchin; Kurt Pfeifer
Journal:  Case Rep Crit Care       Date:  2017-01-10

9.  Human parainfluenza virus type 4 infection in Chinese children with lower respiratory tract infections: a comparison study.

Authors:  Lili Ren; Richard Gonzalez; Zhengde Xie; Zhaohui Xiong; Chunyan Liu; Zichun Xiang; Yan Xiao; Yongjun Li; Hongli Zhou; Jianguo Li; Qingqing Yang; Jing Zhang; Lan Chen; Wei Wang; Guy Vernet; Gláucia Paranhos-Baccalà; Kunling Shen; Jianwei Wang
Journal:  J Clin Virol       Date:  2011-06-01       Impact factor: 3.168

10.  Use of the human colorectal adenocarcinoma (Caco-2) cell line for isolating respiratory viruses from nasopharyngeal aspirates.

Authors:  K H Chan; M K Yan; K K W To; S K Lau; P C Woo; V C C Cheng; W S Li; J F W Chan; H Tse; K Y Yuen
Journal:  J Med Virol       Date:  2013-05       Impact factor: 2.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.